首页> 美国卫生研究院文献>Cancer Management and Research >A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients

【2h】

A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients

机译：Apatinib或Apatinib联合化学疗法治疗复发/晚期卵巢癌患者的疗效和安全性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesDespite recent advances in the treatment of advanced ovarian cancer, drug selection after second-line chemotherapy has not been well studied. In this study, we retrospectively evaluated the effect and safety of apatinib as monotherapy or in combination with chemotherapy for the treatment of advanced ovarian cancer after second-line treatment.

机译：目的尽管在晚期卵巢癌的治疗方面有新进展，但对二线化疗后的药物选择尚未进行充分的研究。在这项研究中，我们回顾性评估了阿帕替尼单药治疗或联合化疗治疗二线治疗后晚期卵巢癌的疗效和安全性。

著录项

期刊名称 Cancer Management and Research
作者
Mi Yang; Xiufeng Liu; Cheng Zhang; Feng Liao; Zixiong Li; Xianwen Luo; Yiran Sun; Chao Chen;
展开▼
作者单位

展开▼
年(卷),期 2019(11),-1
年度 2019
页码 8869–8876
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
apatinib chemotherapy ovarian cancer efficacy and safety;

机译：阿帕替尼;化学疗法;卵巢癌;疗效和安全性;

相似文献

外文文献
中文文献
专利

1. A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients [J] . Mi Yang, Xiufeng Liu, Cheng Zhang, Cancer Management and Research . 2019 ,第3期

机译：Apatinib或Apatinib联合化学疗法治疗复发/晚期卵巢癌的疗效和安全性研究
2. Efficacy and Safety of Apatinib Combined with Etoposide in Patients with Recurrent Platinum-resistant Epithelial Ovarian Cancer: A Retrospective Study [J] . Qi Huang, Chaonan Chu, Jie Tang, Journal of Cancer . 2020 ,第18期

机译：磷钛与依托泊苷中的疗效和安全性在复发性铂抗性上皮癌症患者中的疗效和安全性：回顾性研究
3. The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study [J] . Caiyun Nie, Huifang Lv, Yishu Xing, BMC Cancer . 2021 ,第1期

机译：磷钛治疗治疗晚期或经常性胆道癌症的疗效和安全性：回顾性研究
4. Analysis on the Efficacy and Safety of the Patients with Advanced Ovarian Cancer [C] . Yunxia Xue, Xingyun Sun, Peijing Shi International Forum on Bioinformatics and Medical Engineering . 2015

机译：晚期卵巢癌患者的疗效和安全性分析
5. Integrating genomics and molecular biology: identifying transcriptional targets for the prostate cancer oncogene SOX4 and evaluating the efficacy of Aurora kinase inhibition in chemotherapy-resistant ovarian cancer [D] . Scharer, Christopher D. 2009

机译：整合基因组学和分子生物学：鉴定前列腺癌致癌基因SOX4的转录靶标并评估Aurora激酶抑制作用对化疗耐药的卵巢癌的疗效
6. Efficacy and Safety of Apatinib Combined with Etoposide in Patients with Recurrent Platinum-resistant Epithelial Ovarian Cancer: A Retrospective Study [O] . Qi Huang, Chaonan Chu, Jie Tang, 2020

机译：磷钛与依托泊苷中的疗效和安全性在复发性铂抗性上皮癌症患者中的疗效和安全性：回顾性研究
7. Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial) [O] . Shinichi Komiyama, Kazuyoshi Kato, Yuki Inokuchi, 2018

机译：Bevacizumab联合铂 - 紫杉烷化学疗法作为晚期卵巢癌的一线治疗：日本患者安全性和疗效的前瞻性观察研究（JGOG3022试验）

A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients

摘要

著录项

相似文献

相关主题

期刊订阅